Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Executives On The Move: New Hires In Finance, Science and Leadership At Zimmer, ObsEva And Roche Korea

Executive Summary

Former Bristol-Myers Squibb exec takes CFO spot at Zimmer Biomet and Swiss reproductive health company ObsEva to bring on new CMO. Plus Roche Korea oncology head is now CEO of LEO Pharma Korea.

You may also be interested in...

Execs On The Move, May 2020

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Executives On The Move: New Choices For Finance Spots At Merz Aesthetics, Spruce Biosciences And Lodo Therapeutics

New CFOs are announced at three companies: MerzPharma Group’s Merz Aesthetics; Spruce Biosciences, a firm focusing on treatments for rare endocrine disorders; and Lodo Therapeutics, which is developing novel therapeutics for undruggable targets.

Executives On The Move: Celgene Founder Adds Cerecor To His Chair Portfolio

Sol Barer, founder and former CEO of Celgene, has been appointed chair of Cerecor; he is already chair of Teva, Centrexion Therapeutics and NexImmune. Also, PTC Therapeutics announces promotions and ProBioGen gets a new CEO.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts